-
3m 48sPart 2 | Session 4 STYLE AF Update: Venous Vascular Closure in AF Patients
-
4m 50sPart 2 | Session 5 Balloon-in-Basket PFA without Propofol
-
5m 58sPart 2 | Session 6 ADVENT LTO: Long-Term PFA Outcomes and AF Progression
-
4m 16sPart 3 | Session 1 4 Trials That Will Change My Practice with Dr Luigi Di Biase
-
5m 18sPart 3 | Session 2 AF & EP in 2026: Five Things That Will Change Daily Practice
-
10m 44sPart 1 | Session 1 Complication Prevention in Complex AF and VT Procedures
-
12m 35sPart 1 | Session 2 Will PFA Redefine AF Ablation Strategies in 2026?
-
9m 39sPart 1 | Session 3 Redo AF Ablation: When to Go Beyond PVI?
-
4m 10sPart 2 | Session 1 Stroke Management After AF Ablation
-
7m 20sPart 2 | Session 2 VOLT AF IDE
AF Symposium 2026 - Dr Devi Nair (St Bernards Heart & Vascular, US) joins us to discuss early outcomes from the VERITAS Study, evaluating Abbott's next-generation Amulet 360™ Left Atrial Appendage Occluder for stroke prevention in patients with non-valvular atrial fibrillation.
This pivotal study enrolled 400 patients across 34 centers in the United States, Canada, and Europe. Findings presented first at AF Symposium 2026 demonstrated a 93.9% complete closure rate at 45 days with no peridevice leak greater than 3 mm, alongside favorable early safety outcomes including a 99.8% implant success rate and minimal procedural complications through seven-day follow-up.
Interview Questions:
- What are the current challenges in left atrial appendage closure, and how does the Amulet 360 address unmet needs in this space?
- Can you walk us through the design of the VERITAS Study and your patient population?
- What were the key findings regarding closure rates and early safety outcomes?
- What are the clinical implications of these findings for patient selection and procedural planning in LAA closure?
- What are your key take-home messages for electrophysiologists considering this device for their AFib patients?
- What are the next steps for the VERITAS Study, and when can we expect longer-term efficacy data?
Recorded remotely from Jonesboro, 2026.
Editor: Jordan Rance
Videographer: Oliver Miles, David Ben-Harosh
Support: This is an independent interview produced by Radcliffe Cardiology.
Stay up to date with our video collection covering late-breaking data from AF Symposium 2026 in Boston. Don't miss our short, accessible Expert Interviews, Discussions and Highlights of the most pertinent trials.
More from this programme
Part 1
Clinical Discussions
Part 2
Expert Interviews
Faculty Biographies
Devi Nair
Director of Cardiac Electrophysiology
Dr Devi Nair is a cardiologist and the Director of Cardiac Electrophysiology at St Bernard's Heart and Vascular Center in Arkansas, US. She also holds the position of Assistant Professor of Medicine at the University of Arkansas for Medical Sciences. As an international leader in cardiac rhythm management, Dr Devi Nair specialises in cardiac devices and cardiac ablation therapy.
Dr Devi Nair has won the People's Choice award for the best cardiologist in Jonesboro for the last 5 years.
Dr Devi Nair has made significant contributions to the field through her numerous publications in leading international medical journals. Her extensive medical training began at the University of Kerala, India, followed by residencies at Columbia University College of Physicians & Surgeons and St Luke's Roosevelt Hospital Center in New York, US. She further honed her expertise with fellowships at Case Western Reserve University, US.
Comments